Supersaturation Potential of Amorphous Active Pharmaceutical Ingredients after Long-Term Storage

被引:8
|
作者
Edueng, Khadijah [1 ,2 ]
Mahlin, Denny [1 ,3 ]
Grasjo, Johan [1 ]
Nylander, Olivia [1 ]
Thakrani, Manish [4 ]
Bergstrom, Christel A. S. [1 ,5 ]
机构
[1] Uppsala Univ, Dept Pharm, BMC POB 580,Husargatan 3, S-75123 Uppsala, Sweden
[2] Int Islamic Univ Malaysia, Kulliyyah Pharm, Jalan Istana, Bandar Indera Mahkota 25200, Kuantan Pahang, Malaysia
[3] AstraZeneca Operat, Forskargatan 18, S-15185 Sodertalje, Sweden
[4] UCL, Dept Pharm, Brunswick Sq, London WC1N 1AX, England
[5] Uppsala Univ, Dept Pharm, Swedish Drug Delivery Forum, BMC POB 580,Husargatan 3, S-75123 Uppsala, Sweden
来源
MOLECULES | 2019年 / 24卷 / 15期
基金
欧洲研究理事会; 瑞典研究理事会;
关键词
physical aging; crystallization; amorphous; supersaturation potential; crystallization kinetics; nucleation pathway; crystal growth; dissolution; solvent shift; spray-drying; GLASS-TRANSITION TEMPERATURE; SOLUBILITY ADVANTAGE; POLYMORPHIC SYSTEMS; PHYSICAL STABILITY; CRYSTALLIZATION; DISSOLUTION; WATER; INDOMETHACIN; DRUGS; NUCLEATION;
D O I
10.3390/molecules24152731
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study explores the effect of physical aging and/or crystallization on the supersaturation potential and crystallization kinetics of amorphous active pharmaceutical ingredients (APIs). Spray-dried, fully amorphous indapamide, metolazone, glibenclamide, hydrocortisone, hydrochlorothiazide, ketoconazole, and sulfathiazole were used as model APIs. The parameters used to assess the supersaturation potential and crystallization kinetics were the maximum supersaturation concentration (C-max,C-app), the area under the curve (AUC), and the crystallization rate constant (k). These were compared for freshly spray-dried and aged/crystallized samples. Aged samples were stored at 75% relative humidity for 168 days (6 months) or until they were completely crystallized, whichever came first. The solid-state changes were monitored with differential scanning calorimetry, Raman spectroscopy, and powder X-ray diffraction. Supersaturation potential and crystallization kinetics were investigated using a tenfold supersaturation ratio compared to the thermodynamic solubility using the mu DISS Profiler. The physically aged indapamide and metolazone and the minimally crystallized glibenclamide and hydrocortisone did not show significant differences in their C-max,C-app and AUC when compared to the freshly spray-dried samples. Ketoconazole, with a crystalline content of 23%, reduced its C-max,C-app and AUC by 50%, with C-max,C-app being the same as the crystalline solubility. The AUC of aged metolazone, one of the two compounds that remained completely amorphous after storage, significantly improved as the crystallization kinetics significantly decreased. Glibenclamide improved the most in its supersaturation potential from amorphization. The study also revealed that, besides solid-state crystallization during storage, crystallization during dissolution and its corresponding pathway may significantly compromise the supersaturation potential of fully amorphous APIs.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments
    Van Eerdenbrugh, Bernard
    Raina, Shweta
    Hsieh, Yi-Ling
    Augustijns, Patrick
    Taylor, Lynne S.
    PHARMACEUTICAL RESEARCH, 2014, 31 (04) : 969 - 982
  • [2] What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
    Newman, Ann
    Zografi, George
    MOLECULAR PHARMACEUTICS, 2022, 19 (02) : 378 - 391
  • [3] Classification of the Crystallization Behavior of Amorphous Active Pharmaceutical Ingredients in Aqueous Environments
    Bernard Van Eerdenbrugh
    Shweta Raina
    Yi-Ling Hsieh
    Patrick Augustijns
    Lynne S. Taylor
    Pharmaceutical Research, 2014, 31 : 969 - 982
  • [4] Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties
    Edueng, Khadijah
    Bergstrom, Christel A. S.
    Grasjo, Johan
    Mahlin, Denny
    PHARMACEUTICS, 2019, 11 (09)
  • [5] Benefits and Limitations of Polymorphic and Amorphous Forms of Active Pharmaceutical Ingredients
    Talaczynska, Alicja
    Dzitko, Jakub
    Cielecka-Piontek, Judyta
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (32) : 4975 - 4980
  • [6] An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine
    Baghel, Shrawan
    Cathcart, Helen
    Redington, Wynette
    O'Reilly, Niall J.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 104 : 59 - 71
  • [7] Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions
    Lehmkemper, Kristin
    Kyeremateng, Samuel O.
    Heinzerling, Oliver
    Degenhardt, Matthias
    Sadowski, Gabriele
    MOLECULAR PHARMACEUTICS, 2017, 14 (12) : 4374 - 4386
  • [8] Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs
    Aitipamula, Srinivasulu
    Chow, Pui Shan
    Tan, Reginald B. H.
    CRYSTENGCOMM, 2009, 11 (09): : 1823 - 1827
  • [9] Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters
    Nurzynska, Katarzyna
    Booth, Jonathan
    Robert, Clive J.
    McCabe, James
    Dryden, Ian
    Fischer, Peter M.
    MOLECULAR PHARMACEUTICS, 2015, 12 (09) : 3389 - 3398
  • [10] Measurement of low amounts of amorphous content in hydrophobic active pharmaceutical ingredients with dynamic organic vapor sorption
    Mueller, Thorsten
    Schiewe, Jorg
    Smal, Rudiger
    Weiler, Claudius
    Wolkenhauer, Markus
    Steckel, Hartwig
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 92 : 102 - 111